NEWS RELEASE 3-JUL-2024 A new Mass Eye and Ear-led study is the first to discover that people prescribed semaglutide, sold as Ozempic and Wegovy, have a higher risk of developing a form of blindness due to optic nerve disease known as non-arteritic anterior ischemic optic neurop Peer-Reviewed PublicationMASS EYE AND EAR A new study led...